Nevertheless, the identification of an effect as well as the fact that c5 appear to reduce the PVX latent period and delay the onset of recovery (Table 1) indicates that further studies are warranted to investigate the potential contribution this gene product has for the viral infection cycle. This evidence concerns the gene C5 and viral infectious disease.